—— 要投稿,上万维,轻松学术交流

严正声明

本站非期刊官网,非中介代理,
不向作者收取任何费用!
举报微信:13140028228 冯老师

态度公正、信息求实、投稿自助、使用免费
BIOTECHNOLOGY ADVANCES《生物技术进展》
年8期 - 英国
  • BIOTECHNOLOGY ADVANCES《生物技术进展》
  • SCIE外文期刊
  • 期发文量17
  • 国人占比41.18%
  • 知网外文库
  • 投稿方式--官网投稿
  • 期刊属性

  • 中科分区:1区
    OA期刊:混合
  • 综述期刊:
    TOP期刊:
  • 期均国文:7
    环比增速:83.33%
  • 期刊信息

  • 研究方向:工程技术-BIOTECHNOLOGY APPLIED MICROBIOLOGY生物工程与应用微生物
  • 国际刊号:ISSN 0734-9750;EISSN 1873-1899
  • 期刊语言:英语
    出版地区:英国
  • 投稿网址:https://www.editorialmanager.com/jba
  • 电子邮箱:
  • 期刊官网:https://www.journals.elsevier.com/biotechnology-advances
  • 作者指南:
  • 出版商网址:http://www.elsevier.com
  • 出版地址:THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OX5 1GB
  • 期刊简介:BIOTECHNOLOGY ADVANCES《生物技术进展》(一年8期). Biotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues.

  • 万维提示


  • 1、投稿方式:在线投稿。

    2、期刊网址:

    https://www.journals.elsevier.com/biotechnology-advances

    https://www.sciencedirect.com/journal/biotechnology-advances

    3、投稿网址:https://www.editorialmanager.com/jba

    4、期刊刊期:一年出版8期。

    202211日星期六

                                  

     

    投稿须知【官网信息】

     

    Guide for Authors

    Biotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues. Authoritative articles on current developments and future trends in biotechnology are empathized. Submissions of appropriate manuscripts are invited. A wide audience of scientists, engineers and others is addressed: students, instructors, researchers, practitioners, managers, governments and related stakeholders. Special issues are published on selections of presentations at recent relevant conferences as arranged with the organizations. Special issues are also produced to review areas of biotechnology which are inadequately covered in a focused and/or timely manner in regular issues, as arranged with invited guest editors.

    Types of paper

    Review articles, both short and longer extensive ones are considered. The review article should demonstrate insights of the topic with regard to current developments and future trends in biotechnology. The author(s) should give evidence in the literature of appropriate expertise, for example in the publications cited in the proposed manuscript.

    Contact details for submission

    Papers should be submitted using the Biotechnology Advances online submission system, https://www.editorialmanager.com/jba For questions, please visit our Support Center

    Plagiarism

    All JBA submissions will be subjected to plagiarism evaluation using the software of iThenticate/Crosscheck prior to editorial processing. Authors should be experienced enough to differentiate ethical behaviors (e.g. citation and quotation) from unethical ones (e.g. general plagiarism, self-plagiarism, and copy-and-paste). Manuscripts that cannot pass the plagiarism evaluation pre-screening will be automatically rejected without review and the plagiarism evaluation will not be provided to authors. For more information, please go to: https://www.elsevier.com/editors/perk/plagiarism-detection

    Ethics in publishing

    Please see our information on Ethics in publishing.

    Conflict of interest

    All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within five years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest.

    Submission declaration

    Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.

    ……

    更多详情:

    https://www.elsevier.com/journals/biotechnology-advances/0734-9750/guide-for-authors



欢迎点评!让信息更透明,使投稿更轻松!
  • 审稿时间:
    是否录用:
  • 见刊周期:
    查重要求:
  • 有无课题:
    有无回复:
  • 我的学历:
    我的职称:
  • 审稿费用:
    版面费用:
  • 稿       费:
    稿件字数:
  • 投稿难度:
  • 该刊可发:
  • 投稿主题:
匿名: 验证码: 点击切换验证码
    评分:0

    验证码: 点击切换验证码